EMBO

Molecular Systems Biology has and Impact factor of 9.667 (Journal Citation Report 2010, Thomson Reuters), making it the highest cited title dedicated to systems biology and synthetic biology.

EMBO Molecular Medicine launched in spring 2009, has received its first Impact Factor: 8.833 (Journal Citation Report 2010, Thomson Reuters). The journal ranks 4th among research journals in the ISI category 'Medicine, Research and Experimental' and it has the highest Impact Factor of the journals dedicated to 'Molecular Medicine'.

The EMBO Journal has been EMBO's flagship publication for over 20 years. With a scope that spans all areas of molecular biology, the journal has an international reputation for quality and originality. Published papers are amongst the best in their fields, providing novel insights into biological problems.

EMBO reports publishes high quality scientific research of broad interest and biological significance in all areas of molecular biology. EMBO reports also features expert reviews content from leading researchers that is accessible to both specialist and non-specialist readers, as well as editorial content that offers insight into the broader issues affecting science and society. This diverse range of article types ensures that EMBO reports publishes both important scientific research and insightful commentary from a distinct perspective not found in other publications.

Molecular Systems Biology publishes high-quality research and pioneering technological advances that reveal novel system-level insights in all areas of molecular life sciences. The highest standards are guaranteed by a prestigious Board of Senior and Advisory Editors composed of leading scientists in the fields of Systems Biology, Synthetic Biology and Systems Medicine. Published jointly by Nature Publishing Group and EMBO, Molecular Systems Biology offers immediate open access to its entire content and is committed to accelerating the dissemination of published findings and research data. The Journal has also a dedicated blog, The Seven Stones, which is an online forum for discussions, a natural extension of the journal’s open-access philosophy.

EMBO Molecular Medicine is a new journal devoted to a rapidly developing field where clinical research and molecular biology meet. It publishes high quality research relevant to the understanding, prevention and treatment of human disease. To be one of the first to publish in EMBO Molecular Medicine, contact info @ embomolmed.org.